Mylan India

Mylan India is a significant player in the pharmaceutical sector, dedicated to enhancing global healthcare access through high-quality, affordable medicines. Founded in 1997, the company operates within the Healthcare and Pharmaceuticals industries, focusing on setting new standards in medical provision. Its extensive product portfolio encompasses prescription generic, branded generic, brand-name drugs, biosimilar medications, and over-the-counter remedies, ensuring a broad spectrum of patient needs are met. Mylan India's commitment extends to developing and distributing essential treatments, including APIs, specialty pharmaceuticals, and formulations for critical areas like inhalation and ARV therapies. The company's operational ethos is centered on making quality medicine available and impactful, fostering trust across the healthcare space. With a mission to provide people worldwide access to high-quality medicine, Mylan India actively contributes to public health initiatives and disease management. Meet Mylan India's team to understand the dedicated professionals driving these advancements. The company's scale is reflected in its revenue of $401.7M and an employee range of 500-1,000 employees, indicating a substantial operational footprint. Mylan India maintains a presence across 5 locations, underscoring its reach and capacity to serve diverse markets. Its strategic focus on innovation and accessibility positions it as a key contributor to the pharmaceutical landscape in India and beyond.